TIME COURSE OF INTERFERON LEVELS, ANTIVIRAL STATE, 2',5'-OLIGOADENYLATE SYNTHETASE AND SIDE-EFFECTS IN HEALTHY-MEN

被引：33
作者：
BAROUKI, FM
WITTER, FR
GRIFFIN, DE
NADLER, PI
WOODS, A
WOOD, DL
LIETMAN, PS
机构：
[1] JOHNS HOPKINS UNIV,SCH MED,DEPT PHARMACOL & EXPTL THERAPEUT,BALTIMORE,MD 21205
[2] JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205
[3] HOFFMANN LA ROCHE INC,DIV CLIN PHARMACOL,NUTLEY,NJ 07110
[4] HOFFMANN LA ROCHE INC,DEPT OBSTET & GYNECOL,NUTLEY,NJ 07110
[5] HOFFMANN LA ROCHE INC,DEPT MED,NUTLEY,NJ 07110
[6] HOFFMANN LA ROCHE INC,DEPT NEUROL,NUTLEY,NJ 07110
来源：
JOURNAL OF INTERFERON RESEARCH | 1987年 / 7卷 / 01期
关键词：
D O I：
10.1089/jir.1987.7.29
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：29 / 39
页数：11
相关论文
共 29 条
[1]   2'5'OLIGO(A) POLYMERASE-ACTIVITY AND INHIBITION OF VIRAL-RNA SYNTHESIS IN INTERFERON-TREATED HELA-CELLS [J].
BAGLIONI, C ;
MARONEY, PA ;
WEST, DK .
BIOCHEMISTRY, 1979, 18 (09) :1765-1770
[2]   THE HUMAN INTERFERON SYSTEM [J].
BERMAN, B ;
FRANKFORT, HM .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1982, 21 (01) :12-18
[3]  
CHOUSTERMAN S, 1983, BIOMED PHARMACOTHER, V37, P176
[4]   UNEXPECTEDLY RAPID ACTION OF HUMAN INTERFERON IN PHYSIOLOGICAL CONDITIONS [J].
DIANZANI, F ;
BARON, S .
NATURE, 1975, 257 (5528) :682-684
[5]  
DIANZANI F, 1976, P SOC EXP BIOL MED, V152, P593
[6]  
GALLATI H, 1982, J CLIN CHEM CLIN BIO, V20, P907
[7]   RECOMBINANT LEUKOCYTE-A INTERFERON - PHARMACOKINETICS, SINGLE-DOSE TOLERANCE, AND BIOLOGIC EFFECTS IN CANCER-PATIENTS [J].
GUTTERMAN, JU ;
FINE, S ;
QUESADA, J ;
HORNING, SJ ;
LEVINE, JF ;
ALEXANIAN, R ;
BERNHARDT, L ;
KRAMER, M ;
SPIEGEL, H ;
COLBURN, W ;
TROWN, P ;
MERIGAN, T ;
DZIEWANOWSKI, Z .
ANNALS OF INTERNAL MEDICINE, 1982, 96 (05) :549-556
[8]  
HOVANESSIAN AG, 1979, P NATL ACAD SCI USA, V76, P3261, DOI 10.1073/pnas.76.7.3261
[9]   (2'-5')OLIGOADENYLATE (PPPA2'-5'A2'-5'A)SYNTHETASE AND PROTEIN KINASE(S) FROM INTERFERON-TREATED CELLS [J].
HOVANESSIAN, AG ;
KERR, IM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1979, 93 (03) :515-526
[10]  
HOVANESSIAN AG, 1981, J INTERFERON RES, V2, P179
123